Lumida
/KNSA
⌘K
Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International PLC

KNSA
$76.27USD-0.27%-0.21 today

MARKET CAP

6.0B

P/E (TTM)

83.8x

FWD P/E

DAY RANGE

$76 – $79

52W RANGE

$35
$83

AI Summary

Stalk
StalkMedium

The mid-August Momentum Breakout confirms medium-term bullish asymmetry, but the recent pullback below the 9- and 20-day EMAs alongside a declining RSI signals short-term hesitation. Price remains above the rising 50-day SMA and 200-day SMA, preserving the broader uptrend. Execution should be deferred until price shows acceptance near the 50-day SMA, with a reclaim of the 20-day EMA providing renewed entry readiness.

  • Q4 2025 ARCALYST revenue hit $202.1 M (+65% YoY); FY 2025 total $677.6 M (+62%)
  • Raised full-year 2026 net revenue outlook to $900–920 M after robust Q2
  • Valuation risk: weak earnings yield and low book-to-price metrics suggest limited upside
Full analysis →

Buying

4

institutions

Selling

10

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY2.74 M175.20 M+2.25 M+647.5%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY962.05 K46.39 M+808.62 K+633.5%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY659.49 K42.17 M+18.54 K+36.6%0.05%
FA

Fisher Asset Management, LLC

Q2 2026

SELL398.27 K25.47 M+-30.71 K+23.3%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL375.04 K23.98 M+-3.66 K+31.5%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL309.68 K19.80 M+-190.11 K-17.7%0.03%
MM

Millennium Management LLC

Q2 2026

SELL93.36 K5.97 M+-471.06 K-78.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW68.08 K4.35 M+68.08 K+0.0%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL61.47 K3.93 M+-438.19 K-83.7%0.00%
MG

Man Group Plc

Q2 2026

SELL40.52 K2.59 M+-86.66 K-57.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL31.55 K2.09 M+-75.46 K-57.3%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL4.96 K317.06 K+-48.92 K-87.8%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-134.52 K-100.0%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-21.00 K-100.0%0.00%